Treatments

Covid shots designed to protect against the omicron variant trigger a weaker immune response against the rapidly emerging BQ.1.1 subvariant than the previously dominant strain, according to a new lab study.

Scientists at the University of Texas Medical Branch, in a study published online Tuesday in Nature Medicine, found that the booster shots performed well against the BA.5 subvariant they were designed to target.

Country / Region Tags:

Global

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds
Log in or register to post comments

New study spotlights disparities in COVID-19 clinical trials

Wed, 2022-12-07 12:08 — mike kraft

Study spotlights disparities in COVID-19 clinical trials | CIDRAP

A study yesterday in JAMA Internal Medicine shows women and racial minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.

The research was conducted by a team from the Fred Hutchinson Cancer Center, as well researchers from Beijing and London.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about New study spotlights disparities in COVID-19 clinical trials
Log in or register to post comments

China changes strategy, rolls back anti-COVID measures following protests

Wed, 2022-12-07 09:52 — mike kraft

China eases anti-COVID measures following protests BEIJING (AP) — China rolled back rules on isolating people with COVID-19 and dropped virus test requirements for some public places Wednesday in a dramatic change to a strategy that confined millions of people to their homes and sparked protests and demands for President Xi Jinping to resign . AP NEWS

...

Country / Region Tags:

Asia

China

Global

Problem, Solution, SitRep, or ?:

Situation Report

Read more about China changes strategy, rolls back anti-COVID measures following protests
Log in or register to post comments

EU backs bivalent Covid shots, UK supports vaccinating infants over 6 months

Tue, 2022-12-06 18:52 — mike kraft

EU regulator backs bivalent COVID shots for primary vaccination The European Medicines Agency said on Tuesday its emergency task force has concluded that messenger RNA bivalent COVID-19 vaccines, targeting the original strain and the Omicron BA.4-5 subvariants, may be used in previously unvaccinated children and adults. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU backs bivalent Covid shots, UK supports vaccinating infants over 6 months
Log in or register to post comments

National COVID-⁠19 Preparedness Plan --White House Press Release

Tue, 2022-12-06 18:36 — mike kraft

National COVID-19 Preparedness Plan | The White House Today, the U.S. government is releasing the National COVID-19 Preparedness Plan – which will enable America to move forward safely, sustaining The White House

...

The President’s National COVID-19 Preparedness Plan focuses on four key goals:

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about National COVID-⁠19 Preparedness Plan --White House Press Release
Log in or register to post comments

Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug

Tue, 2022-12-06 11:09 — mike kraft

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug Pfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer and Clear Creek Bio partner to develop oral COVID-19 drug
Log in or register to post comments

COVID vaccine hesitancy linked to 'nocebo' side effects--study

Tue, 2022-12-06 10:44 — mike kraft

COVID vaccine hesitancy linked to 'nocebo' side effects CIDRAP

Vaccine hesitancy about COVID-19 vaccines is a positive predictor of negative side effects with vaccination—an example of the "nocebo" effect—according to a study today in Scientific Reports.

Nocebo, a play on placebo, is a phenomenon in which people experience negative effects on health when they have negative views or expectations surrounding medical interventions.

Country / Region Tags:

General Topic Tags: